John Babitt, Ernst & Young, Pulse of the Industry report at AdvaMed 2015

2015 MedTech Highlights: Low Industry Growth, VC Declines, M&A Impressive

By MedTech Intelligence Staff
No Comments
John Babitt, Ernst & Young, Pulse of the Industry report at AdvaMed 2015

Ernst & Young’s Pulse of the Industry report is out, and once again, it’s not all gloom and doom.

The annual Ernst & Young Medical technology report 2015, Pulse of the Industry was released at last week’s AdvaMed 2015 conference and was met with a bit of apprehension. In an interview with MedTech Intelligence, John Babitt, partner, transaction advisory services at Ernst & Young, reviews the key concerns for the medtech industry, along with the areas of opportunity.

Areas of strength include the IPO market, with 43 companies going public in the 12-month period that ended June 30, and 16 mergers and acquisitions deals in excess of $1 billion. The gloom and doom enters in the category of overall single-digit industry growth, which saw only 2% growth, along with the decline in venture capital.

Leave a Reply

Your email address will not be published. Required fields are marked *